Alcohol use and abuse is common in many societies and is associated with adverse effects on health. According to the US National Institute on Alcohol Abuse and Alcoholism, in 2019, an estimated 14.1 million adults aged 18 years and older had alcohol use disorder, defined as "chronic relapsing brain disease characterized by an impaired ability to stop or control alcohol use despite adverse social, occupational, or health consequences." 1 Among the numerous alcohol-related diseases and harms, including liver cirrhosis, obesity, some cancers, injury, and suicide, only some directly contribute to acute critical illness. However, among patients with alcohol use or abuse who require intensive care unit (ICU) or hospital admission, alcohol withdrawal is an important factor that may complicate treatment and increase the risk of adverse outcomes.Alcohol activates γ-aminobutyric acid type A (GABA A ) receptors, initially suppressing inhibitory neurotransmitter systems (relaxing social inhibitions) and, at higher levels, reducing consciousness. Chronic use induces tolerance by downregulating GABA A receptors. Abrupt abstinence induces a hyperexcitable state within 6 to 24 hours, characterized by anxiety, agitation, sympathetic activity, and hallucinations and seizures in severe cases. Alcohol withdrawal, rather than alcohol use per se, is the more common reason for alcoholrelated issues among patients admitted to the ICU. A systematic review from 2013 found that the prevalence of alcohol withdrawal syndrome (AWS) in general ICU populations ranged from 0.5% to 8%, but was up to 52% among patients with alcohol-related admissions. 2 However, the same review also found "little high quality data for how best to prevent, diagnose and treat AWS in the ICU." 2 The first challenge is to identify patients at greatest risk for AWS. No validated tool exists for patients admitted to the ICU, but scoring tools for hospitalized patients in non-ICU settings (eg, the Prediction of Alcohol Withdrawal Severity Scale) 3 highlight the importance of previous withdrawal episodes, seizures, hallucinations, alcohol rehabilitation treatment, and other substance abuse. Various risk thresholds for the reported habitual quantity of alcohol consumed have been proposed, but no consensus has been reached. 2 Several preventive strategies have been studied in critically ill patients considered at high risk of AWS, including ethanol, flunitrazepam, clonidine, clomethiazole, haloperidol, and diazepam, with disappointing or inconclusive results due to poor study design. 2 Most guidelines 4 for care in the ICU and elsewhere emphasize treatment over prophylaxis and require the development of specific symptoms and signs of alcohol withdrawal before medication administra-